ArticleNucleic acids research2026
SpliceImpactR maps alternative RNA processing events driving protein functional diversity.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Alternative RNA processing is a key regulator of gene expression, shaping transcript and protein diversity essential for cell function. Yet, how distinct alternative RNA processing events alter protein function remains unclear. Here, we introduce SpliceImpactR-available as a Bioconductor package and interactive R Shiny application-an open-source framework that systematically identifies RNA isoform switches across the human transcriptome, including alternative first and last exons, exon skipping, intron retention, hybrid exons, and splice site variants, and predicts their impact on encoded proteins. Applying SpliceImpactR across all annotated human isoforms and 17 350 samples spanning 54 tissues, we find that intron retention and hybrid exons frequently shift protein-coding transcripts into non-coding isoforms. Strikingly, when both isoforms remain protein-coding, 87% of alternative RNA processing events produce substantial changes in protein sequence. Widespread frameshifts introduced by alternative splicing are often rescued by co-regulated downstream exons, uncovering a buffering mechanism that maintains protein integrity. Alternative last exons drive the most extensive structural changes, while alternative first exons emerge as the most efficient mechanism for reshaping tissue-specific protein domain architecture. We further found that alternative RNA processing events are widely co-regulated and undergo gradual, tissue-specific transitions rather than binary on/off switches. In the cerebellum, we found that alternative first exons progressively increase and activate nuclear localization signals, while in colon adenocarcinoma internal splicing events rewire key oncogenic protein interactions. Together, SpliceImpactR delivers a proteome-wide atlas of splicing regulation, establishing a powerful, accessible platform to decode how context-dependent RNA processing drives human proteomic and tissue diversity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.